20180208: ICC NF140, NF186 and NF155 IgG and IgM CMT patients

Objectives: To test CMP patients for IgM and IgG positivity towards NF140, NF186 and NF155.

Patients:

For NF140 and NF186:

NUMBERNAME AND SURNAMECODE
1Blai Batista Roige056-16
2Gemma Carreras Colomer074-02
3Rosa Maria Martinez Fernandez191-01
4Asunción Nieto Romero107-01
5Enrique Torrats Fontanelles028-19
6Jose Torres Nieto107-02
7Ivan Patrici Santiago Varzulli177-16
8Pilar España Hervás166-04
9Prudencio Colmenero Lazaño
10Luis Piqué Vilanova
11CTRL -

For NF155:

NUMBERNAME AND SURNAMES
1Prudencio Colmenero Lazaño
2Luis Piqué Vilanova
3CTRL -
4CTRL + 15.195

NF140 ICC:

  • HEKs 293 Cells Transfection: 2018.01.16
  • Blocking solution: 5% goat serum in PBS.
  • Patient’s sera diluted 1/10 for IgM and diluted 1/100 for IgG with 5% goat serum in PBS.
  • Primary antibody: AF3235 diluted 1/1000.
  • Secondary antibodies:
    • For IgG: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
    • For IgM: GAC 488 (1/1000) + GAH 594 IgM (1/1000)
  • Vectashield mounting medium.

NF186 ICC:

  • HEKs 293 Cells Transfection: ?
  • Blocking solution: 5% goat serum in PBS.
  • Patient’s sera diluted 1/10 for IgM and diluted 1/100 for IgG with 5% goat serum in PBS.
  • Primary antibody: AF3235 diluted 1/1000.
  • Secondary antibodies:
    • For IgG: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
    • For IgM: GAC 488 (1/1000) + GAH 594 IgM (1/1000)
  • Vectashield mounting medium.

NF155 ICC:

  • HEKs 293 Cells Transfection: 2018.01.16
  • Blocking solution: 5% goat serum in PBS.
  • Patient’s sera diluted 1/10 for IgM and diluted 1/100 for IgG with 5% goat serum in PBS.
  • Primary antibody: AF3235 diluted 1/1000.
  • Secondary antibodies:
    • For IgG: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
    • For IgM: GAC 488 (1/1000) + GAH 594 IgM (1/1000)
  • Vectashield mounting medium.

Results: All samples were negative except the positive control (sample 4 of NF155).

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.